Kramer, D., Stark, N., Schulz-Heddergott, R., Erytch, N., Edmunds, S., Roßmann, L., . . . Dobbelstein, M. (2018). Correction: Strong antitumor synergy between DNA crosslinking and HSP90 inhibition causes massive premitotic DNA fragmentation in ovarian cancer cells. Cell Death Differ.
Chicago Style CitationKramer, Daniela, et al. "Correction: Strong Antitumor Synergy between DNA Crosslinking and HSP90 Inhibition Causes Massive Premitotic DNA Fragmentation in Ovarian Cancer Cells." Cell Death Differ 2018.
Cita MLAKramer, Daniela, et al. "Correction: Strong Antitumor Synergy between DNA Crosslinking and HSP90 Inhibition Causes Massive Premitotic DNA Fragmentation in Ovarian Cancer Cells." Cell Death Differ 2018.
Atenció: Aquestes cites poden no estar 100% correctes.